Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the ELSS median (51 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 03 Jan 2022 – 20 Aug 2026, limited by Sundaram ELSS Tax Saver Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Sundaram ELSS Tax Saver Fund | Nifty 500 |
|---|---|---|
| 03 Jan 2022 | ₹100.00 | ₹100.00 |
| 24 May 2022 | ₹90.89 | ₹90.42 |
| 12 Oct 2022 | ₹100.64 | ₹97.54 |
| 02 Mar 2023 | ₹99.02 | ₹95.94 |
| 20 Jul 2023 | ₹115.39 | ₹112.09 |
| 08 Dec 2023 | ₹124.25 | ₹123.01 |
| 27 Apr 2024 | ₹137.22 | ₹137.06 |
| 15 Sep 2024 | ₹155.53 | ₹157.37 |
| 03 Feb 2025 | ₹142.87 | ₹140.76 |
| 24 Jun 2025 | ₹152.66 | ₹152.01 |
| 11 Nov 2025 | ₹157.39 | ₹155.76 |
| 01 Apr 2026 | ₹138.82 | ₹137.69 |
| 20 Aug 2026 | ₹151.81 | ₹154.64 |
| Metric | Sundaram · Regular NAV ₹502.93 Very High risk ★★★☆☆ | Category median ELSS · 51 funds |
|---|---|---|
| -3.01% | +2.06% | |
| +10.00% | +13.00% | |
| — | +12.22% | |
| — | +12.69% | |
| +9.44% | +13.09% | |
| +8.71% | — | |
| +14.19% | +14.73% | |
| — | +15.15% | |
| — | +14.10% | |
| Risk | ||
| 13.11% | 14.18% | |
| 0.27 | 0.47 | |
| 0.36 | 0.63 | |
| -16.88% | -37.97% | |
| Nifty 500 | — | |
| -1.34% | +0.84% | |
| 0.90 | 0.97 | |
| 87.9% | 100.1% | |
| 91.2% | 95.6% | |
| 2.28% | 1.93% | |
| ₹1,254Cr | ₹857.48Cr | |
| None | — | |
| 3 years | — | |
| ₹500 | — | |
| ₹500 | — | |
| 60% | 33% | |
| Sudhir Kedia | — | |
| 03 Jan 2022 | — | |
| 54 | — | |
| 42.5% | — | |
| 1.9% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.